(Q34046989)
Statements
1 reference
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial (English)
1 reference
Bartosz Chmielowski
William D Tap
Brian A Van Tine
Anthony D Elias
Douglas Adkins
Mark Agulnik
Matthew M Cooney
Michael B Livingston
Gregory Pennock
Meera R Hameed
Gaurav D Shah
Amy Qin
Ashwin Shahir
Damien M Cronier
Robert Ilaria
Ilaria Conti
Jan Cosaert
9 June 2016
1 reference